Drugs Made In America Acquisition Corp. - 8-K Filing
Drugs Made In America Acquisition Corp. amends merger agreement with Power Analytics Global Corp., setting a fixed closing valuation of $2.85B for PAGC including APQC acquisition. (Items: 1.01 Entry into a Material Definitive Agreement, 9.01 Financial Statements and Exhibits)
Tickers: $DMAAU